Sectra AB (MIL:1SECT) Peter Lynch Fair Value: €3.58 (As of Jun. 27, 2026) — 38% Below Median


MIL:1SECT Sectra AB MIL:1SECT
76 GF Score
Price €27.38
GF Value €28.93
Valuation Fairly Valued
View Full Analysis

What is Sectra AB Peter Lynch Fair Value?

Sectra AB MIL:1SECT 76 Peter Lynch Fair Value is €3.58 as of Jun. 27, 2026, which is 100% below its 10-year median of 5.75. GuruFocus rates MIL:1SECT with a GF Score™ of 76/100 and a GF Value™ of €28.93 (Fairly Valued). Among 152 Medical Devices & Instruments companies, Sectra AB ranks worse than 95.39% on this metric.

Peter Lynch Fair Value applies to growing companies. The ideal range for the growth rate is between 10 - 20% a year. Peter Lynch thinks that the fair P/E value for a growth company equals its growth rate, that is PEG = 1. The earnings here is trailing twelve month (TTM) earnings. For non-bank companies, the growth rate we use is the average growth rate for EBITDA per share over the past 5 years. For Banks, the growth rate we use is the average growth rate for Book Value per share over the past 5 years. If 5-Year Growth Rate is greater than 25% a year, we use 25. If 5-Year Growth Rate is smaller than 5% a year, we do not calculate Peter Lynch Fair Value.

Here, as of today, Sectra AB's PEG is 1. Sectra AB's 5-Year TTM EBITDA Growth Rate is 13.29. Sectra AB's EPS without NRI for the trailing twelve months (TTM) ended in Apr. 2026 was €0.27. Therefore, the Peter Lynch Fair Value for today is €3.58.

As of today (2026-06-27), Sectra AB's share price is €27.38. Sectra AB's Peter Lynch fair value is €3.58. Therefore, Sectra AB's Price to Peter Lynch Fair Value Ratio for today is 7.66.


The historical rank and industry rank for Sectra AB's Peter Lynch Fair Value or its related term are showing as below:

MIL:1SECT' s Price-to-Peter-Lynch-Fair-Value Range Over the Past 10 Years
Min: 2.98   Med: 5.75   Max: 8.44
Current: 5.89


During the past 13 years, the highest Price to Peter Lynch Fair Value Ratio of Sectra AB was 8.44. The lowest was 2.98. And the median was 5.75.


MIL:1SECT's Price-to-Peter-Lynch-Fair-Value is ranked worse than
95.39% of 152 companies
in the Medical Devices & Instruments industry
Industry Median: 1.53 vs MIL:1SECT: 5.89

Note: Please don't confuse Peter Lynch Fair Value with the value reached in Peter Lynch Chart.


Sectra AB  (MIL:1SECT) Peter Lynch Fair Value Explanation

Peter Lynch Fair Value applies to growing companies. The ideal range for the growth rate is between 10 - 20% a year.

Peter Lynch thinks that the fair P/E value for a growth company equals its growth rate, that is PEG = 1. The earnings here is trailing twelve month (TTM) earnings. For non-bank companies, the growth rate we use is the average growth rate for EBITDA per share over the past 5 years. For Banks, the growth rate we use is the average growth rate for Book Value per share over the past 5 years.

Please don't confuse Peter Lynch Fair Value with the value reached in Peter Lynch Chart. In Peter Lynch chart, a fixed P/E ratio of 15 is used to draw the Earnings Line. Therefore the value reached has a P/E ratio of 15. But in Peter Lynch Fair Value calculation, P/E equals to the growth rate of EBITDA per share over the past 5 years, which is 13.29 instead of 15 in this case.

Sectra AB's Price to Peter Lynch Fair Value Ratio for today is calculated as

Price to Peter Lynch Fair Value=Share Price/Peter Lynch Fair Value
=27.38/3.58
=7.66

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sectra AB Peter Lynch Fair Value Related Terms


Sectra AB Peter Lynch Fair Value Historical Data

* Premium members only.

The historical data trend for Sectra AB's Peter Lynch Fair Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sectra AB Peter Lynch Fair Value Chart

Sectra AB Annual Data
Trend Apr17 Apr18 Apr19 Apr20 Apr21 Apr22 Apr23 Apr24 Apr25 Apr26
Peter Lynch Fair Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Sectra AB Quarterly Data
Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26 Apr26
Peter Lynch Fair Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

MIL:1SECT vs ABT, SYK, MDT: Peter Lynch Fair Value Comparison

For the Medical Devices subindustry, Sectra AB's Price-to-Peter-Lynch-Fair-Value, along with its competitors' market caps and Price-to-Peter-Lynch-Fair-Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sectra AB Price-to-Peter-Lynch-Fair-Value vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Sectra AB's Price-to-Peter-Lynch-Fair-Value distribution charts can be found below:

* The bar in red indicates where Sectra AB's Price-to-Peter-Lynch-Fair-Value falls into.


MIL:1SECT
76GF Score
Sectra AB MIL:1SECT
Peter Lynch Fair Value is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sectra AB Peter Lynch Fair Value Calculation

Sectra AB's Peter Lynch Fair Value for today is calculated as

Peter Lynch Fair Value=PEG Ratio*5-Year TTM EBITDA Growth Rate***EPS without NRI (TTM)
=1* 13.29 *0.269
=3.58

Sectra AB's EPS without NRI for the trailing twelve months (TTM) ended in Apr. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.27.


* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** Please be aware that the 5-Year TTM EBITDA Growth Rate is calculated based on TTM data over the last 5 years. For quarterly reported companies, the TTM data adds up the quarterly data reported by the company within the most recent 12 months. For companies that report semi-annually, annually, or do not have enough quarterly data, GuruFocus uses the annual data as the TTM data.

If 5-Year Earnings Growth Rate is greater than 25% a year, we use 25.

If 5-Year Earnings Growth Rate is smaller than 5% a year, we do not calculate Peter Lynch Fair Value.

Please note that we use the 5-year average growth rate of EBITDA per share as the growth rate for non-bank companies, as EBITDA growth is subject to less manipulations than net earnings per share. For banks, we use the 5-year average growth rate of Book Value per share as the growth rate. The reason is that EBITDA is not applicable to Banks and Book value is a relative important measurement for Banks. In the calculation, PEG=1 because Peter Lynch thinks that the fair P/E ratio of the growth stock is equal to its earnings growth rate.

Frequently Asked Questions Learn more about Peter Lynch Fair Value →
What does a Peter Lynch Fair Value of €3.58 mean?
Sectra AB (MIL:1SECT) has a Peter Lynch Fair Value of €3.58 as of Jun. 27, 2026. Peter Lynch Fair Value is the stock value based on a company's current earnings and five-year earnings growth, assuming a PEG of one. View historical data on Sectra AB and its competitors. This is 38% below median its historical median of 5.75. Over the past decade, Sectra AB's Peter Lynch Fair Value has ranged from 2.98 to 8.44. According to the industry distribution chart, Sectra AB ranks #145 out of 152 companies in the Medical Devices & Instruments industry, placing it in the top 95.4%.
Is Sectra AB's Peter Lynch Fair Value too high?
Sectra AB's current Peter Lynch Fair Value of €3.58 is 38% below median its 10-year median of 5.75. Over the past 10 years, this metric has ranged from a low of 2.98 to a high of 8.44. Based on the distribution chart, Sectra AB ranks #145 out of 152 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Sectra AB has a GF Score™ of 76/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Sectra AB's Peter Lynch Fair Value compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Sectra AB ranks #145 out of 152 companies for Peter Lynch Fair Value. This places Sectra AB in the lower half of its industry. The industry median Peter Lynch Fair Value is 1.53. Historically, Sectra AB's own Peter Lynch Fair Value has ranged from 2.98 to 8.44 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Peter Lynch Fair Value for a Medical Devices & Instruments company?
The median Peter Lynch Fair Value among Medical Devices & Instruments companies is 1.53, based on 152 companies in the industry. Companies in the top quartile (top 25%) have a Peter Lynch Fair Value significantly above this median, while those in the bottom quartile fall well below. However, Peter Lynch Fair Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Peter Lynch Fair Value mean?
A high Peter Lynch Fair Value can signal that a stock is expensive relative to its fundamentals. Peter Lynch Fair Value is the stock value based on a company's current earnings and five-year earnings growth, assuming a PEG of one. View historical data on Sectra AB and its competitors. For the Medical Devices & Instruments industry, the median Peter Lynch Fair Value is 1.53 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sectra AB's current Peter Lynch Fair Value is €3.58, which is 38% below median its own 10-year median of 5.75. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sectra AB stock overvalued right now?
Based on GuruFocus' analysis, Sectra AB (MIL:1SECT) is currently considered Fairly Valued. The stock's GF Value™ is €28.93, compared to a current price of €27.38 — trading 5.4% below its estimated fair value. The current Peter Lynch Fair Value is €3.58, which is 38% below median its 10-year median of 5.75. Sectra AB's overall GF Score™ is 76/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Peter Lynch Fair Value calculated?
Peter Lynch Fair Value is calculated from a company's financial statements. For Sectra AB (MIL:1SECT), the current Peter Lynch Fair Value is €3.58 as of Jun. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Sectra AB (MIL:1SECT) Overvalued in 2026?

Based on GuruFocus' analysis, Sectra AB stock appears to be undervalued. The current stock price of €27.38 is trading 5.4% below its estimated GF Value™ of €28.93. GuruFocus considers Sectra AB to be Fairly Valued.

Key valuation signals for MIL:1SECT:

  • Peter Lynch Fair Value: €3.58 (38% below median its 10-year median of 5.75)
  • GF Value™: €28.93 vs. price of €27.38 (5.4% below fair value)
  • GF Score™: 76/100

No single metric tells the full story. See the MIL:1SECT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Sectra AB Business Description

Address Teknikringen 20, Linkoping, SWE, 583 30
Sectra AB develops IT solutions and services for storing, viewing, and working with medical images. The operating business segments are Imaging IT Solutions, Secure Communications, Business Innovation, and Other Operations. It generates maximum revenue from the Imaging IT Solutions segment. The company also offers maintenance in the form of support, system monitoring, and consulting services related to integration, system design, data migration, and business development. Geographically, it derives a majority of its revenue from the United States, followed by Sweden, the United Kingdom, the Netherlands, the Rest of Europe, and the Rest of the world.
76GF Score

Get the complete analysis for MIL:1SECT

Peter Lynch Fair Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€27.38
Price
€28.93
GF Value